These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11244294)

  • 1. Gene therapy in the neuroendocrine system: its implementation in experimental models using viral vectors.
    Bolognani F; Goya RG
    Neuroendocrinology; 2001 Feb; 73(2):75-83. PubMed ID: 11244294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroendocrinology of aging: the potential of gene therapy as an interventive strategy.
    Goya RG; Bolognani F; Hereñú CB; Rimoldi OJ
    Gerontology; 2001; 47(3):168-73. PubMed ID: 11340324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential of gene therapy for the treatment of pituitary tumors.
    Goya RG; Sarkar DK; Brown OA; Hereñú CB
    Curr Gene Ther; 2004 Mar; 4(1):79-87. PubMed ID: 15032616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene therapy in the neuroendocrine system.
    Hereñú CB; Morel GR; Bellini MJ; Reggiani PC; Sosa YE; Brown OA; Goya RG
    Front Horm Res; 2006; 35():135-142. PubMed ID: 16809929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on in vivo gene transfer in pituitary tumors using herpes-derived and adenoviral vectors.
    Carri NG; Sosa YE; Brown OA; Albariño C; Romanowski V; Goya RG
    Brain Res Bull; 2005 Feb; 65(1):17-22. PubMed ID: 15680541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of an E1E4-deleted adenovirus expressing the herpes simplex thymidine kinase suicide gene in cancer gene therapy.
    Lanuti M; Gao GP; Force SD; Chang MY; El Kouri C; Amin KM; Hughes JV; Wilson JM; Kaiser LR; Albelda SM
    Hum Gene Ther; 1999 Feb; 10(3):463-75. PubMed ID: 10048398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenovirus-mediated herpes simplex virus type-1 thymidine kinase gene therapy suppresses oestrogen-induced pituitary prolactinomas.
    Windeatt S; Southgate TD; Dewey RA; Bolognani F; Perone MJ; Larregina AT; Maleniak TC; Morris ID; Goya RG; Klatzmann D; Löwenstein PR; Castro MG
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1296-305. PubMed ID: 10720079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenovirus-mediated gene transfer of enhanced Herpes simplex virus thymidine kinase mutants improves prodrug-mediated tumor cell killing.
    Wiewrodt R; Amin K; Kiefer M; Jovanovic VP; Kapoor V; Force S; Chang M; Lanuti M; Black ME; Kaiser LR; Albelda SM
    Cancer Gene Ther; 2003 May; 10(5):353-64. PubMed ID: 12719705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of HSV-1 thymidine kinase-dependent and -independent inhibition of replication-competent adenoviral vectors by a panel of drugs.
    Wildner O; Hoffmann D; Jogler C; Uberla K
    Cancer Gene Ther; 2003 Oct; 10(10):791-802. PubMed ID: 14502232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters.
    Ebara S; Shimura S; Nasu Y; Kaku H; Kumon H; Yang G; Wang J; Timme TL; Aguilar-Cordova E; Thompson TC
    Prostate Cancer Prostatic Dis; 2002; 5(4):316-25. PubMed ID: 12627218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
    Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
    J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of a novel oncolytic adenoviral vector and its biological characteristics.
    Zhang M; Zhang X; Han Z; Chen X; Yang L; Sheng Y; Wen J
    Oncol Rep; 2013 Feb; 29(2):798-804. PubMed ID: 23165979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term gene therapy in the CNS: reversal of hypothalamic diabetes insipidus in the Brattleboro rat by using an adenovirus expressing arginine vasopressin.
    Geddes BJ; Harding TC; Lightman SL; Uney JB
    Nat Med; 1997 Dec; 3(12):1402-4. PubMed ID: 9396613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue-targeted in vivo gene transfer coupled with histone deacetylase inhibitor depsipeptide (FK228) enhances adenoviral infection in rat renal cancer allograft model systems.
    Kobayashi M; Okada T; Murakami T; Ozawa K; Kobayashi E; Morita T
    Urology; 2007 Dec; 70(6):1230-6. PubMed ID: 18158067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor reduction in vivo after adenoviral mediated gene transfer of the herpes simplex virus thymidine kinase gene and ganciclovir treatment in human head and neck squamous cell carcinoma.
    Goebel EA; Davidson BL; Graham SM; Kern JA
    Otolaryngol Head Neck Surg; 1998 Oct; 119(4):331-6. PubMed ID: 9781985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of adenovirus-mediated CD/5-FC and HSV-1 thymidine kinase/ganciclovir suicide gene therapies concomitant with p53 gene therapy.
    Xie Y; Gilbert JD; Kim JH; Freytag SO
    Clin Cancer Res; 1999 Dec; 5(12):4224-32. PubMed ID: 10632364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy of head and neck squamous cell carcinoma with an oncolytic adenovirus expressing HSV-tk.
    Morris JC; Wildner O
    Mol Ther; 2000 Jan; 1(1):56-62. PubMed ID: 10933912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenoviral-mediated delivery of the herpes simplex virus thymidine kinase gene selectively sensitizes human ovarian carcinoma cells to ganciclovir.
    Rosenfeld ME; Feng M; Michael SI; Siegal GP; Alvarez RD; Curiel DT
    Clin Cancer Res; 1995 Dec; 1(12):1571-80. PubMed ID: 9815958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene therapy for hepatocellular carcinoma: chemosensitivity conferred by adenovirus-mediated transfer of the HSV-1 thymidine kinase gene.
    Wills KN; Huang WM; Harris MP; Machemer T; Maneval DC; Gregory RJ
    Cancer Gene Ther; 1995 Sep; 2(3):191-7. PubMed ID: 8528962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted expression of toxic genes directed by pituitary hormone promoters: a potential strategy for adenovirus-mediated gene therapy of pituitary tumors.
    Lee EJ; Anderson LM; Thimmapaya B; Jameson JL
    J Clin Endocrinol Metab; 1999 Feb; 84(2):786-94. PubMed ID: 10022454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.